IOL CHEMICALS & PHARM. | BERYL DRUGS | IOL CHEMICALS & PHARM./ BERYL DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 15.0 | 89.9% | View Chart |
P/BV | x | 1.5 | 2.2 | 69.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. BERYL DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BERYL DRUGS Mar-23 |
IOL CHEMICALS & PHARM./ BERYL DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 18 | 2,981.7% | |
Low | Rs | 272 | 8 | 3,629.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 53.0 | 712.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.5 | 1,568.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 3.1 | 1,012.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 15.9 | 1,614.2% | |
Shares outstanding (eoy) | m | 58.71 | 5.07 | 1,158.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.2 | 445.3% | |
Avg P/E ratio | x | 17.1 | 8.4 | 202.1% | |
P/CF ratio (eoy) | x | 12.8 | 4.1 | 313.2% | |
Price / Book Value ratio | x | 1.6 | 0.8 | 196.4% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 65 | 36,717.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 15 | 11,312.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 269 | 8,245.7% | |
Other income | Rs m | 256 | 3 | 9,212.2% | |
Total revenues | Rs m | 22,427 | 272 | 8,255.6% | |
Gross profit | Rs m | 2,257 | 20 | 11,357.3% | |
Depreciation | Rs m | 462 | 8 | 5,670.8% | |
Interest | Rs m | 165 | 5 | 3,526.8% | |
Profit before tax | Rs m | 1,887 | 10 | 19,171.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2 | 22,711.0% | |
Profit after tax | Rs m | 1,391 | 8 | 18,164.5% | |
Gross profit margin | % | 10.2 | 7.4 | 137.7% | |
Effective tax rate | % | 26.2 | 22.1 | 118.5% | |
Net profit margin | % | 6.3 | 2.8 | 220.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 104 | 9,284.9% | |
Current liabilities | Rs m | 5,025 | 64 | 7,823.8% | |
Net working cap to sales | % | 20.9 | 14.8 | 141.2% | |
Current ratio | x | 1.9 | 1.6 | 118.7% | |
Inventory Days | Days | 43 | 14 | 305.5% | |
Debtors Days | Days | 8 | 937 | 0.9% | |
Net fixed assets | Rs m | 11,017 | 71 | 15,585.5% | |
Share capital | Rs m | 587 | 51 | 1,152.5% | |
"Free" reserves | Rs m | 14,490 | 30 | 48,739.0% | |
Net worth | Rs m | 15,077 | 81 | 18,692.3% | |
Long term debt | Rs m | 0 | 27 | 0.0% | |
Total assets | Rs m | 20,684 | 175 | 11,832.9% | |
Interest coverage | x | 12.5 | 3.1 | 400.8% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.5 | 69.7% | |
Return on assets | % | 7.5 | 7.1 | 106.7% | |
Return on equity | % | 9.2 | 9.5 | 97.2% | |
Return on capital | % | 13.6 | 13.4 | 101.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 25 | 4,930.2% | |
From Investments | Rs m | -1,200 | -13 | 9,216.6% | |
From Financial Activity | Rs m | -41 | -12 | 352.2% | |
Net Cashflow | Rs m | -18 | 0 | -15,333.3% |
Indian Promoters | % | 48.2 | 26.4 | 182.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 73.6 | 70.4% | |
Shareholders | 130,003 | 6,852 | 1,897.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | BERYL DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.00% | -1.30% | 0.13% |
1-Month | 9.32% | 14.79% | 2.47% |
1-Year | -0.21% | 145.61% | 52.94% |
3-Year CAGR | -11.21% | 85.88% | 14.90% |
5-Year CAGR | 15.71% | 37.24% | 19.34% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the BERYL DRUGS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of BERYL DRUGS the stake stands at 26.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of BERYL DRUGS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
BERYL DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of BERYL DRUGS.
For a sector overview, read our pharmaceuticals sector report.
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.